Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase 2 Clinical Trial of an Anti-Androgen and A 5-Alpha Reductase Inh-261075017
Mayo Foundation
Search grants from Mayo Foundation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Functional and Molecular Dissection of Myeloproliferative Neoplasm Stem Cells
(PQC5 in RFA-CA-12-020) Using MR phase to detect ferritin tagged breast cancer ce
Delay Discounting and the Choice to Take a Drug
Cancer Following Bone Marrow Transplantation
Isolate Characterization of Plasma Lypoprotein Apolyprop
Recently added grants:
Embryonic vascular stem-progenitors for treatment of ischemic retinopathies
Combining modeling and experiments to study the evolution of cells with altered ploidy
Structural and functional characterization of protective antibodies induced in peanut oral immunotherapy
Direct chemical control of the hematopoietic master transcription factor PU.1
Statistical and high-throughput models of enhancer function and evolution
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA075017-008
Application #
7329467
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2006
Total Cost
Indirect Cost
Institution
Name
Mayo Foundation
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2006
N01 CA
Phase 2 Clinical Trial of an Anti-Androgen and A 5-Alpha Reductase Inh-261075017
/ Mayo Foundation
NIH 2003
N01 CA
Phase 2 Clinical Trial of an Anti-Androgen and A 5-Alpha Reductase Inh-261975017
/ Mayo Foundation
Comments
Be the first to comment on this grant